Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport  by Schönfeld, Peter & Wojtczak, Lech
1767 (2007) 1032–1040
www.elsevier.com/locate/bbabioBiochimica et Biophysica ActaFatty acids decrease mitochondrial generation of reactive oxygen species at
the reverse electron transport but increase it at the forward transport
Peter Schönfeld a,⁎, Lech Wojtczak b
a Institut für Biochemie, Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany
b Nencki Institute of Experimental Biology, Pasteura 3, 02093 Warsaw, Poland
Received 27 February 2007; received in revised form 11 April 2007; accepted 22 April 2007
Available online 3 May 2007Abstract
Long-chain nonesterified (“free”) fatty acids (FFA) can affect the mitochondrial generation of reactive oxygen species (ROS) in two ways: (i)
by depolarisation of the inner membrane due to the uncoupling effect and (ii) by partly blocking the respiratory chain. In the present work this dual
effect was investigated in rat heart and liver mitochondria under conditions of forward and reverse electron transport. Under conditions of the
forward electron transport, i.e. with pyruvate plus malate and with succinate (plus rotenone) as respiratory substrates, polyunsaturated fatty acid,
arachidonic, and branched-chain saturated fatty acid, phytanic, increased ROS production in parallel with a partial inhibition of the electron
transport in the respiratory chain, most likely at the level of complexes I and III. A linear correlation between stimulation of ROS production and
inhibition of complex III was found for rat heart mitochondria. This effect on ROS production was further increased in glutathione-depleted
mitochondria. Under conditions of the reverse electron transport, i.e. with succinate (without rotenone), unsaturated fatty acids, arachidonic and
oleic, straight-chain saturated palmitic acid and branched-chain saturated phytanic acid strongly inhibited ROS production. This inhibition was
partly abolished by the blocker of ATP/ADP transfer, carboxyatractyloside, thus indicating that this effect was related to uncoupling
(protonophoric) action of fatty acids. It is concluded that in isolated rat heart and liver mitochondria functioning in the forward electron transport
mode, unsaturated fatty acids and phytanic acid increase ROS generation by partly inhibiting the electron transport and, most likely, by changing
membrane fluidity. Only under conditions of reverse electron transport, fatty acids decrease ROS generation due to their uncoupling action.
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Generation of “reactive oxygen species“ (ROS) by mito-
chondria was first described by Chance and co-workers [1–3].
Superoxide (O2
U−) is formed as side-product of the respiratoryAbbreviations: AA, antimycin A; Ara, arachidonic acid; CDNB, 1-chloro-
2,4-dinitrobenzene; CAT, carboxyatractyloside; Cyt c, cytochrome c; FCCP,
carbonyl cyanide 4-trifluoro-methoxyphenylhydrazone; FET, forward electron
transport; FFA, free fatty acids; RHM, rat heart mitochondria; RLM, rat liver
mitochondria; Rot, rotenone; ROS, reactive oxygen species; Lin, linoleic acid;
Mal, malate; Myr, myristic acid; Ole, oleic acid; Pal, palmitic acid; Phyt,
phytanic acid; Pyr, pyruvate; RET, reverse electron transport; Succ, succinate;
Δψm, mitochondrial membrane potential
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within complex I (NADH-ubiquinone oxidoreductase) and
complex III (ubiquinol-cytochrome c oxidoreductase) [4,5]. In
contrast to complex III, where O2
U− generation is attributed to
ubisemiquinone as electron donor [3,6,7], the site of complex I-
associated O2
U− generation is still under discussion. Fe–S clusters
[8], the flavine mononucleotide [9,10] and the region around
ubisemiquinone-binding sites [11] have been discussed as
electron donor sites. Moreover, O2
U− is released from complex I
to the matrix side of the inner membrane, whereas complex III
releases O2
U− to both sides of the inner membrane [12–14]. O2U− is
rapidly converted to H2O2 by the Mn-containing superoxide
dismutase (inside mitochondria) or the Cu,Zn-containing super-
oxide dismutase (intermembrane space and cytosol) [5]. H2O2 is
decomposed by catalase or reduced to H2O by glutathione
peroxidase.
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mitochondria from state 4 (resting state) to state 3 (active state)
decreases respiratory chain-associated ROS generation [2].
Similarly, the chemical protonophore FCCP or free long-chain
fatty acids (FFA) decrease ROS generation by succinate-
oxidizing rat heart mitochondria [15,16]. These observations
indicate that even a slight depolarisation of the inner
mitochondrial membrane abolishes mitochondrial ROS genera-
tion (mild uncoupling concept, [7]). The mild uncoupling
concept has stimulated a lot of experimental work to stress the
role of the mitochondrial membrane potential (Δψm), and also
that of the uncoupling proteins (for review see [17]), in mito-
chondrial ROS generation. From these studies, mostly done
with isolated mitochondria from rat brain and heart, the
following conclusions can be drawn: (i) mitochondria oxidizing
NAD-linked substrates (e.g. pyruvate plus malate) generate a
low level of ROS by complex I and, in addition, this level
decreases only moderately by depolarisation with FCCP [18–
20]. (ii) Mitochondria oxidizing NAD-linked substrates respond
to rotenone (complex I inhibitor) or antimycin A (complex III
inhibitor) with a dramatic increase in ROS generation, although
both inhibitors collapse Δψm. (iii) In contrast, when complex I
is supplied with electrons deriving from the reversed electron
transport (RET), mitochondrial ROS generation decreases
severely after addition of rotenone or FCCP [15,18]. (iv) ROS
generation by mitochondria respiring with succinate plus
rotenone is poor, but increases dramatically after addition of
antimycin A. (v) Depletion of cytochrome c from mitochondria
increases ROS generation [21].
Tissues contain small amounts of FFA, which are mostly
bound to proteins and membranes [22]. The concentration of
total nonesterified fatty acids in human plasma is about 0.5 mM
and can be tripled under fasting [23] or doubled under physical
exercise [24]. FFA also accumulate in tissues during ischemia
and in peroxisomal diseases [25,26]. There is evidence that FFA
are involved in ischemia arrhythmias, reperfusion injury,
cardiac dysfunction in diabetes and impaired insulin secretion
as well as insulin action [25,27–29]. There is reason to assume
that FFA are present in tissues at a similar concentration range
as in blood. However, their actual distribution between various
cellular structures is not known. Nevertheless, it seems that the
concentrations of FFA applied in the present study (80 μM
maximum), similar to those used by other cited authors, are
within the physiological or pathological conditions. As
protonophoric uncouplers and inhibitors of the respiratory
chain [30–33], FFA are able to modulate mitochondrial ROS
generation by uncoupling and interfering with the electron
transport. In addition, FFA can also impair the electron transport
as consequence of the release of cytochrome c from the external
side of the inner membrane [21,34].
To date, the available data on the effect of FFA on
mitochondrial ROS generation are controversial. As mentioned
above [16], FFA abolish ROS generation by rat heart mito-
chondria under condition of RET (succinate as substrate),
whereas FCCP-uncoupled rat heart mitochondria respond to
high concentrations of FFA with increased ROS generation
[31]. In addition, stimulation of ROS generation by FFA wasalso reported from a study using rat brain and heart
mitochondria respiring with NAD-linked substrates in rest
[33]. Consequently, the mechanism underlying the modulation
of mitochondrial ROS by FFA remains unclear. To get more
insight into these relationships, in the present investigation we
treated rat heart and liver mitochondria with low, micromolar,
concentrations of various fatty acids, including saturated,
unsaturated and branched-chain FFA. The results demonstrated
that the protonophoric action of FFA does not significantly
affect ROS generation by mitochondria at the forward electron
transport (FET). On the opposite, some FFA (especially Phyt,
Lin and Ara) remarkably stimulate ROS, whereas Pal increases
ROS generation only at a relative high concentration. Finally,
ROS generation associated with complex III is reciprocally
correlated with the inactivation of its enzymatic activity by
FFA.2. Materials and methods
2.1. Preparation of mitochondria
Heart mitochondria were isolated by differential centrifugation from tissue
homogenates obtained from adult female Wistar rats (average weight 150–
180 g) essentially as described in [35]. Before tissue homogenisation, pieces of
heart tissue were treated with trypsin. The mitochondrial pellet was resuspended
in 0.25 M sucrose at a concentration of 10–12 mg×ml−1. Liver mitochondria
were prepared by differential centrifugation of tissue homogenates as described
in [36]. The mitochondrial pellet was resuspended in 0.25 M sucrose at a
concentration of 25–35 mg×ml−1. Protein contents in the stock suspensions
were determined by biuret method using bovine serum albumin as standard.
Functional integrity of mitochondrial preparations was estimated by the
respiratory control ratio, which was routinely higher than 10 using pyruvate
plus malate (RHM) and 8 using glutamate plus malate (RLM) as substrates.
The standard incubation medium was composed of 110 mM mannitol,
60 mM KCl, 60 mM Tris–HCl, 10 mM KH2PO4, 0.5 mM EGTA (pH 7.4). The
medium was supplemented with 5 mM Pyr plus 5 mMMal or with 10 mM Succ
as respiratory substrates. Stock solutions of fatty acids and respiratory chain
inhibitors were made in ethanol.
2.2. Oxygen uptake
Oxygen uptake by mitochondria was measured using an oxygraph
(Oroboros Oxygraph®, Bioenergetics and Biomedical Instruments, Innsbruck,
Austria).
2.3. ROS generation
ROS generation was estimated as the release of H2O2 from mitochondria.
For this purpose oxidation of Amplex Red (non-fluorescent) to resorufin
(fluorescent) was followed fluorimetrically [37]. Briefly, mitochondria (0.2 mg
mitochondrial protein×ml−1) were incubated in the standard incubation medium
supplemented with 5 μMAmplex Red plus horseradish peroxidase (2 U×ml−1)
to detect H2O2 and Cu,Zn-superoxide dismutase (2 U×ml
−1) for quantitative
conversion of released O2
U− into H2O2. Resorufin fluorescence was monitored by
Perkin-Elmer Luminescence spectrometer LS 50B (excitation at 560 nm,
emission at 590 nm). The increase in resorufin fluorescence was calibrated with
H2O2. Addition of arachidonic or phytanic acids at the concentrations used in
this work had no effect on the calibration curve.
2.4. Complex III activity
Complex III activity was measured essentially as described by Trumpower
and Ewards [38]. Before measuring enzymatic activity, mitochondria were
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Absorption changes were measured in the standard incubation medium using a
Cary 3E UV-Visible Spectrophotometer.
Ubiquinol–cytochrome c oxidoreductase (complex III) was assayed by
monitoring the initial rate of reduction of oxidized cytochrome c by
decylubiquinol at 550 nm (ε=19.2 cm2×μmol−1). As described above, all
components (including 10 μg of the mitochondrial sample) except decylubi-
quinol (50 μM) were added into both the sample and the reference cells.
Decylubiquinol was reduced by adding a small crystal of NaBH4 to a solution of
commercial decylubiquinone in ethanol. When the reaction mixture became
colourless, the liquid was transferred to another tube (omitting the crystal),
acidified by addition of 0.1 volume of 1 M HCl and stored at −20 °C [39].
2.5. Chemicals
Fatty acids (except phytanic acid), FCCP, rotenone, antimycin A, 1-chloro-
2,4-dinitrobenzene (CDNB), Cu,Zn-superoxide dismutase, horseradish perox-
idase (Type VI-A), decylubiquinone, cytochrome c and carboxyatractyloside
were from Sigma-Aldrich Chemie GmbH (Sternheim, Germany). Phytanic acid
was supplied by ULTRA Scientific (North Kingstown, RI) and Amplex Red by
Invitrogen (Eugene, Oregon). Trypsin was from Serva (Heidelberg, Germany).
2.6. Data analysis
Statistical analysis was performed using Prism 3.0 software (GraphPad
Software, San Diego, CA). Significance was examined by the unpaired t test.Fig. 1. Stimulation of ROS generation by increasing concentrations of Pal, Ara and P
plus Rot. FFAwere added to final concentrations of 20, 40 and 80 μM, corresponding
i.e. under conditions of RET, in the absence of FFA is also shown for comparison
preparations.pb0.05 was considered statistically significant with respect to control
incubation.
3. Results
3.1. FFA stimulate ROS generation supported by the forward
electron transport (FET)
FFA can modulate ROS generation in mitochondria in state 4
either by uncoupling or by interference with the respiratory
chain. The effect of FFA on ROS generation accompanying
FET was studied in rat heart and liver mitochondria supplied
with Succ (plus Rot) or Pyr plus Mal and treated with 20, 40 and
80 μM of Pal, Phyt or Ara (corresponding to 100, 200 and
400 nmol FFA per mg protein). Fig. 1 shows that ROS
generation increased with increasing concentrations of Phyt or
Ara. FFA-linked ROS generation was higher with Succ (plus
Rot) than with Pyr plus Mal (compare panels A and B or C and
D). In RHM, Phyt was the most potent inducer of ROS (panels
A and B), whereas in RLM Phyt and Ara produced a similar
increase in ROS generation (panels C and D). In contrast, Pal
only slightly stimulated ROS generation.hyt. Mitochondria from heart or liver were incubated with Pyr plus Mal or Succ
to 100, 200 and 400 nmol×mg protein−1. ROS production in the absence of Rot,
(full squares). Data shown are means±SD obtained from 4 to 6 mitochondrial
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electron transport (RET)
The effect of FFA on ROS production accompanying RET
was investigated in mitochondria oxidizing Succ in the absence
of Rot (Fig. 2). Firstly, it has to be noted that omission of RotFig. 2. Effect of FFA on ROS production driven by reverse electron transport.
RHM suspended in 1 ml incubation medium (0.2 mg protein) were supplied with
Succ (10 mM) in the absence of Rot. (A) Pal, Phyt, Ole or Ara was added to a
final concentration of 20 μM (corresponding to 100 nmol×mg protein−1). The
concentration of FCCP was 0.1 μM. (B) RHM were treated with increasing
concentrations of FFA (0.5 to 5 μM). Rates of ROS production were expressed
as percentage of ROS production in the absence of added FFA (100%
corresponds to 251±45 pmol H2O2×min
−1×mg protein−1). Data were from
four mitochondrial preparations. (C) Respiration and ROS generation was
recorded for RHM treated with Pal (10 nmol×mg protein−1). CATwas added at
the concentration of 5 μM.remarkably increased ROS production from about 30 to about
250 pmol×min− 1 ×mg protein− 1 for RHM (Fig. 1, panel B)
and from about 25 to about 60 pmol×min− 1 ×mg protein− 1 for
RLM (Fig. 1, panel D). Pal, Phyt, Ole and Ara (20 μM,
corresponding to 100 nmol FFA per mg protein) strongly
decreased ROS generation, similarly as the chemical uncoupler
FCCP (Fig. 2, panel A). Even such a low concentration of FFA
as 1 μM (corresponding to 5 nmol×mg protein− 1) diminished
ROS production by 50% (Fig. 2, panel B). This decrease of
RET-linked ROS production by FFA was most likely due to
their protonophoric activity, which prevents the RET from Succ
to complex I by decreasingΔψm. Protonophoric activity of FFA
is explained by a cyclic movement of protonated and
deprotonated forms of fatty acids across the inner mitochondrial
membrane, mostly supported by the adenine nucleotide
antiporter [40,41] that can be inhibited by carboxyatractyloside
(CAT). High recoupling by CAT has been observed in FFA-
uncoupled heart mitochondria [42]. Therefore, the effect of
recoupling on Pal-suppressed ROS production was examined.
Indeed, recoupling by CAT (indicated as a decrease of
respiration) was paralleled by reactivation of ROS production
(Fig. 2, panel C).
3.3. Fatty acid uncoupling does not change fatty acid-induced
ROS generation
In contrast, when RET was blocked by Rot, electrons were
transported from Succ exclusively to complex III (FET). At this
situation, the basal ROS production was lower and was
stimulated by FFA (Fig. 1). It could be hypothesised that this
stimulation was the resultant of an inhibitory effect of FFA on
the electron transport through the respiratory chain. Addition of
Phyt to RHM fuelled with Succ (plus Rot) in state 4 stimulated
the respiration in a concentration-dependent manner that was
partly reversed by CAT (Fig. 3, panels A and C). It can also be
seen that immediately after addition of the highest applied
concentration of Phyt (Fig. 3, panel A, trace c; 100 nmol Phyt
per mg protein), the respiration was first stimulated, but slowed
down thereafter. Stimulation of respiration reflects the uncou-
pling activity of Phyt, which induced the depolarisation of the
inner membrane. However, in contrast to the recoupling effect
of CAT on respiration, Phyt-stimulated ROS generation was not
changed by CAT (Fig. 3, panels B and C). These rates of
respiration and corresponding ROS generation are summarized
in panel C. It can be seen that CAT partly reversed FFA-
associated increase of respiration, but was without effect on
ROS generation. These findings clearly indicate that stimulation
of ROS production at FET by such FFA as Myr, Phyt or Lin was
not affected by their protonophoric activities.
3.4. Fatty acids stimulate ROS generation in
glutathione-depleted mitochondria
Mitochondrial ROS generation is buffered by the matrix
content of reduced glutathione. Thus, depletion of glutathione
enhances ROS generation [43,44]. With this in mind, we
examined whether depletion of glutathione could affect ROS
Fig. 4. Effect of glutathione depletion on FFA-induced ROS generation. RHM
(0.2 mg protein) suspended 1.0 ml of the incubation medium were supplemented
with Succ plus Rot. Mitochondria were depleted of glutathione by addition of
30 μM CDNB. (A) Antimycin A and FFAwere added to final concentrations of
2 μM and 20 μM (corresponding to 100 nmol×mg protein−1), respectively. (B)
Rates of ROS production obtained with Myr, Pal, Phyt, Ole, Lin, Ara and
antimycin A (AA). ROS production in mitochondria treated with CDNB alone
was 126 pmol×min−1×mg protein−1 and was assumed as 100% (control). Data
are means±SD obtained from 3 to 5 mitochondrial preparations. *pb0.05 versus
control.
Fig. 3. Effect of carboxyatractyloside on FFA-stimulated respiration and ROS
generation. (A) Oxygen uptake. RHM (1 mg protein) oxidising Succ (plus Rot)
were treated with 12.5, 25 and 50 μM Phyt (corresponding to 25, 50 and
100 nmol×mg protein−1, traces a–c, respectively). (B) ROS generation. RHM
(0.2 mg protein) were treated with 5, 10 and 20 μM Phyt (corresponding to 25,
50 and 100 nmol×mg protein−1). CATwas added at the concentration of 5 μM.
(C) RHM (0.2 mg or 1 mg protein) were treated with Myr, Phyt or Lin
(corresponding to 50 nmol×mg protein−1). At the ordinate axis, the rates of
respiration (O2) are expressed in nmol×min
−1×mg protein−1 and those of H2O2
release in pmol×min−1×mg protein−1. Data are means±SD obtained from 3 to
5 mitochondrial preparations. *pb0.05 versus respiration without CAT.
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dinitrobenzene (CDNB) [45]. It was found that such treatment
of heart mitochondria strongly increased ROS generation and,
when Phyt or AA was added, a further increase of ROS
generation was found (Fig. 4, panel A). In addition, unsaturated
FFA, Ole, Lin, and Ara were also able to increase ROSproduction by glutathione-depleted RHM (Fig. 4, panel B).
Such stimulation of ROS generation by FFA in glutathione-
depleted mitochondria clearly indicates that FFA-associated
ROS generation in untreated mitochondria was most likely due
to an interference with the electron transport rather than with the
amount or the rate of generation of reduced glutathione within
the mitochondrial compartment (see Discussion).
3.5. Complex III-associated ROS generation correlates with
inactivation of its enzymatic activity
As demonstrated above, the stimulation of ROS generation
by FFA was more steeply dependent on FFA concentration in
case of Succ oxidation than with NAD-linked substrates (Fig.
1). Therefore, the enzymatic activity of complex III (expressed
as the rate of decylubiquinol oxidation by oxidised Cyt c) was
measured at increasing concentrations of Pal, Phyt and Ara. It
was found that in RHM the enzymatic activity of complex III
became strongly decreased with increasing concentrations of
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5, panel A). In contrast, Pal and Ara were similarly inhibitory to
complex III in RLM, but both these FFAwere weaker inhibitors
than Phyt (Fig. 5, panel B). Rates of ROS generation and
enzymatic activities were plotted against each other in Fig. 6.
These plots show that for Phyt and Ara there was a reverse
linear correlation between complex III activity and ROS
generation in heart mitochondria (Fig. 6, panel A) over the
whole range of complex III activity. In contrast, in RLM ROS
generation was not affected by partial inhibition of the
respiratory activity by up to about 30% for Ara and by up to
70% by Phyt (Fig. 6, panel B). Also surprisingly and in contrast
to RHM, total inhibition of complex III by antimycin A in RLM
was accompanied by a negligible increase in ROS production
only.
3.6. Fatty acids enhance ROS production at blocked complex I
It is known that incorporation of FFA in the inner mito-
chondrial membrane increases the membrane fluidity [46,47],
which can change membrane-associated energy coupling
processes [48]. Therefore, it can be hypothesised that FFAFig. 5. Inactivation of complex III by FFA. Complex III was measured as
described in Materials and methods. Activity of the control incubation was
2010±84 (RHM) or 1528±162 (RLM) nmol×min−1×mg protein−1, respec-
tively. Data are means±SD obtained from 3 to 4 mitochondrial preparations.
Fig. 6. FFA-associated ROS generation is reciprocally correlated with complex
III activity. Rates of ROS generation were taken from Fig. 1. The graphs show
the increase of ROS generation by increasing inhibition of complex III activity
in RHM (A) and RLM (B).facilitate the access of O2 to electron-donating sites within the
respiratory chain and, in addition, the release of O2
U−. To
examine such possibility, the effect of various FFAwas studied
on RHM suspended in the standard medium containing Pyr plus
Mal additionally supplemented with Rot, the situation where the
electron transport via complex I was blocked. It was found that
under such condition addition of Rot considerably enhanced
ROS generation and that this increase was further enhanced by
FFA (Fig. 7). Phyt and Lin strongly stimulated ROS production,
Ara was somewhat less effective and Pal exerted only slight
effect if any. Furthermore, stimulation of ROS production by
these FFA was found also when RHM were incubated with 2-
oxoglutarate plus Rot or succinate plus Rot plus antimycin A
(not shown). In conclusion, these observations indicate that
FFA can enhance O2
U− production under conditions where the
electron transport by complex I or complex III is blocked.
Similar results were also obtained with brain mitochondria (not
shown).
4. Discussion
It has been reported that ROS production by mitochondria
under resting state conditions (state 4) is more or less decreased
by depolarisation of the inner membrane [15,18–20]. In isolated
Fig. 7. Effect of FFA on ROS generation of rotenone-treated mitochondria.
RHM (0.2 mg protein) suspended 1.0 ml of the incubation medium were
supplemented with Pyr (5 mM) plus Mal (5 mM) plus Rot (5 μM). Pal, Phyt, Ara
and Lin were added to final concentration of 20 μM (corresponding to
100 nmol×mg protein−1). Data are means±SD from 3 to 5 mitochondrial
preparations. *pb0.05 versus control with Rot only .
1038 P. Schönfeld, L. Wojtczak / Biochimica et Biophysica Acta 1767 (2007) 1032–1040mitochondria, this decline depends on the respiratory substrate
used. Thus, mitochondria oxidising Succ generate high amounts
of ROS due to RET. This generation is abolished even by a
slight decrease of Δψm [2,15]. The reason why such thermo-
dynamically unfavourable backward transport of electrons from
complex III to NAD+ generates more O2
U− than their forward
transport from NADH through complex I to complex III is not
fully understood. Transition from state 4 to state 3, accompanied
by some lowering of Δψm, is associated with a considerable
decrease of ROS production in Succ-oxidising mitochondria
which can be returned to its state 4 level by addition of CAT
(blocking ADP/ATP exchange) or oligomycin (blocking ADP
phosphorylation) [49]. As expected, ROS production by
mitochondria functioning in the RET mode is strongly
decreased by Rot, since the O2
U− production in complex I
(most likely related with its FMN moiety) is upstream of the site
where Rot blocks the electron transport (for review see [50]).
The physiological role of RET is strongly debatable and so are
its possible functions in in vivo ROS generation and the
resulting tissue damage, e.g. in ischemia/reperfusion or
neurodegenerative diseases (discussed in [51]).
In contrast, ROS generation is relatively low in mitochondria
energized with NAD+-linked substrates (e.g., Pyr plus Mal),
despite that mitochondria are highly energized and matrix
NAD+ is mostly reduced. The same is true for mitochondria
oxidising Succ in the presence of Rot, i.e., under conditions
supporting FET. Under these situations, ROS production is also
much less sensitive to agents dissipatingΔψm [18,19,20,52] but
is strongly increased by blockers of the respiratory chain, like
Rot [21] and antimycin A [6], although the latter agents collapse
Δψm.
Since FFA are not only physiological protonophores but also
inhibitors of the ADP/ATP exchange and of the electron
transport (for review see [22]), they can be expected to modulate
the mitochondrial ROS production in different ways. In fact, it
was observed in the present work that unsaturated long-chain
fatty acids, Lin and Ara, and the saturated branched-chain fattyacid Phyt stimulated ROS production, whereas saturated fatty
acids Myr and Pal were less active or without effect (Figs. 1, 3
and 4). This observation was remarkable, as all these FFA acted
as week uncouplers (Figs. 2 and 3) by increasing resting state
respiration in a CAT-sensitive way [40,41]. Moreover, unsatu-
rated fatty acids and Phyt appeared to decrease the rate of
uncoupled respiration with both NAD-linked substrates and
Succ (plus Rot) [30,31,33]. Interestingly, at higher concentra-
tions they were also inhibitory in state 4 respiration [30,31,33].
This finding confirms the long-known dual effect of FFA on
mitochondrial respiration (also reviewed in [22]): protonophoric
action on the inner mitochondrial membrane and inhibitory
action on the electron transfer chain.
Having this in mind, we may explain stimulation of
mitochondrial ROS production by unsaturated fatty acids and
Phyt as being due to the inhibition of electron transport, the
effect similar to that exerted by antimycin A or rotenone. Thus,
by inhibition of the electron transport across complexes I and III
of the respiratory chain, FFA promote the one-electron reducing
mechanism of molecular oxygen. A similar increase of ROS
production by Pal and Ara was found in FCCP-uncoupled RHM
by Cocco et al. [31]. Interference of FFAwith the mitochondrial
electron transport is well documented [30–33], although its
molecular mechanism is not well understood. Interestingly, the
respiratory chain as a whole and its complexes I and III have also
been shown to be inhibited by fatty acid derivatives ceramide
[53] and N-arachidonoylethanolamine [54]. Both these com-
pounds also increased mitochondrial ROS production under
specific conditions [53,54]. Here we have shown that complex
III becomes inactivated by Pal, Phyt and Ara in permeabilized
mitochondria in a concentration-dependent manner (Fig. 5).
Despite a direct inhibitory action of FFA at certain sites of
the electron transport chain, FFA could induce mitochondrial
depletion of Cyt c [27,34,55]. In addition, incorporation FFA
into the mitochondrial membrane was found to increase its
fluidity [46–48], an interaction that may likely affect function-
ing of the respiratory chain and, presumably, also the production
of O2
U−. Thus, treatment of beef heart submitochondrial particles
with erucic acid (cis-13-docosenoic acid) increased O2
U−
production and membrane fluidity [47]. In addition, we have
shown that FFA enhance the release of O2
U− from complex I in
Rot-treated RHM (Fig. 7). It is also worthy mentioning that,
under our experimental conditions, inhibition of complex III
activity by antimycin A in RLM had only a negligible
stimulatory effect on ROS production, whereas Phyt and Ara
exerted a potent effect (Fig. 6, panel B). These observations
indicate that inhibition of the respiratory chain by FFA is not the
only factor stimulating ROS production. This additional effect
of FFA may facilitate the so-called “electron leak” due to
changes in membrane fluidity. A more detailed analysis of the
mechanism(s) by which FFA hamper electron transport and thus
increase ROS production is, however, beyond the aims of this
work.
The question can be, however, asked whether other ways of
this increase are possible. One of them could be depletion of the
mitochondrial glutathione pool. Reduced glutathione removes
mitochondrially generated H2O2 in a reaction catalysed by
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glutathione is regenerated by the operation of glutathione
reductase that utilizes NADPH as electron donor [56]. The latter
compound is maintained in its reduced form due to the
functioning of inner membrane-bound transhydrogenase utiliz-
ing NADH as reductant. This reaction is endergonic and
depends on Δψm as the energy source [57]. Thus, decrease of
Δψm by FFA due to their protonophoric action (mild
uncoupling) might affect as well the scavenging ability of the
mitochondrial matrix and increase ROS generation. In order to
examine whether this might be the case, we investigated the
effect of FFA on ROS production in glutathione-depleted
mitochondria. As expected, glutathione depletion by itself
resulted in a moderate increase of ROS generation. Never-
theless, this generation was further strongly increased by Phyt
and, to a smaller extent, by Ara (Fig. 4). This result indicates
that the increase of ROS production induced by FFA, similarly
as that induced by antimycin A, was due to blocking the
respiratory chain rather than to decreasing the scavenging action
of the glutathione system. This conclusion is further reinforced
by a correlation observed between stimulation of ROS
generation and inhibition of complex III activity (Fig. 6).
In conclusion, the present results provide strong evidence
that, in mitochondria functioning in FET mode, FFA boost ROS
production by inhibiting the electron transport rather than
decrease ROS generation due to their mild uncoupling action as
proposed by the Skulachev's group [7,15,16].
A different situation occurs in case of RET. In this situation
high production of ROS is related to a high degree of the
reduction of complex I that is, in turn, coupled to high Δψm.
Any agents preventing RET, like inhibitors of the respiratory
chain between complexes I and III (e.g., Rot), or protonophores
(e.g. FCCP) could be expected to drastically diminish ROS
production. In fact, the latter mechanism operates in case of low,
micromolar, concentrations of Pal, Ole, Phyt and Ara, which
appeared as potent inhibitors of ROS generation, with IC50 of
about 5 nmol/mg protein (Fig. 2). In analogy, short-chain
ceramides [53] and N-acylethanolamines [54], which are
probably not protonophores by themselves but increase proton
conductance of the inner mitochondrial membrane by some
other mechanism(s), also inhibit ROS production based on RET.
In this point it could still be discussed whether FFA decrease
Succ-dependent ROS production due to a moderate depolarisa-
tion of the inner membrane (FCCP-like effect) or due to
inhibition of RET by a direct interference with the respiratory
chain (rotenone-like effect). However, reactivation of the Pal-
suppressed ROS production by CAT clearly indicates that FFA
suppress ROS generation in RET by their protonophoric
activity (Fig. 2C).
In conclusion, with exception of RET-associated ROS
production, FFA increase ROS generation driven by NAD+-
linked substrates in heart and liver mitochondria of rat.
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